CellPly Company
Developing analytical systems to characterize next-generation cancer immunotherapy
Founded Date:
2013-01-01
Last Funding Type:
Venture - Series Unknown
Headquarters:
Bologna, Emilia-Romagna, Italy
Investors Number:
8.0
Technology:
Biotechnology, Health Care, Medical
Employee Number:
1-10
Industry:
Preclinical Development
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-12-15
Funding Status:
Seed
Total Funding:
6690000.0